Skip Nav Destination
OnlineFirst
Research Article May 24 2022
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes
Cécile Alanio; Zev A. Binder; Renee B. Chang; MacLean P. Nasrallah; Devora Delman; Joey H. Li; Oliver Y. Tang; Logan Y. Zhang; Jiasi Vicky Zhang; E. John Wherry; Donald M. O'Rourke; Gregory L. Beatty
Cancer Immunol Res (2022)
Research Article May 23 2022
Comprehensive characterizations of immune receptor repertoire in tumors and cancer immunotherapy studies
Li Song; Zhangyi Ouyang; David Cohen; Yang Cao; Jennifer Altreuter; Gali Bai; Xihao Hu; Kenneth J. Livak; Heng Li; Ming Tang; Bo Li; X. Shirley Liu
Cancer Immunol Res canimm.0965.2021.
Research Article May 20 2022
Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multi-Omics Analysis
Xuanwen Bao; Qiong Li; Jinzhang Chen; Diyu Chen; Chanqi Ye; Xiaomeng Dai; Yanfang Wang; Xin Li; Xiaoxiang Rong; Fei Cheng; Ming Jiang; Zheng Zhu; Yongfeng Ding; Rui Sun; Chuan Liu; Lingling Huang; Yuzhi Jin; Bin Li; Juan Lu; Wei Wu; Yixuan Guo; Wenguang Fu; Sarah Raye Langley; Vincent Tano; Weijia Fang; Tiannan Guo; Jianpeng Sheng; Peng Zhao; Jian Ruan
Cancer Immunol Res canimm.1101.2022-1-3 09:35:19.220.
Research Article May 19 2022
P2RX7 enhances tumor control by CD8+ T cells in adoptive cell therapy.
Kelsey M. Wanhainen; Changwei Peng; Maggie H. Zhou; Bruna de Gois Macedo; Stephen O'Flanagan; Tingyuan Yang; Ameeta Kelekar; Brandon J. Burbach; Henrique Borges da Silva; Stephen C. Jameson
Cancer Immunol Res canimm.0691.2021.
Research Article May 19 2022
Systemic immune dysfunction in cancer patients driven by IL6 induction of LAG3 in peripheral CD8+ T cells
Ashwin Somasundaram; Anthony R. Cillo; Caleb Lampenfeld; Creg J. Workman; Sheryl Kunning; Lauren N. Oliveri; Maria Velez; Sonali Joyce; Michael Calderon; Rebekah Dadey; Dhivyaa Rajasundaram; Daniel P. Normolle; Simon C. Watkins; James G. Herman; John M. Kirkwood; Evan J. Lipson; Robert L. Ferris; Tullia C. Bruno; Dario A.A. Vignali
Cancer Immunol Res canimm.0736.2020.
Research Article May 18 2022
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma
Sui Peng; Shuling Chen; Wei Hu; Jie Mei; Xuezhen Zeng; Tianhong Su; Wei Wang; Zebin Chen; Han Xiao; Qian Zhou; Bin Li; Yubin Xie; Huanjing Hu; Minghui He; Yanyan Han; Longqing Tang; Yifan Ma; Xiaoshuang Li; Xiangjun Zhou; Zihao Dai; Zelong Liu; Jiehui Tan; Lixia Xu; Shaoqiang Li; Shunli Shen; Dongming Li; Jiaming Lai; Baogang Peng; Zhenwei Peng; Ming Kuang
Cancer Immunol Res (2022)
Research Article May 17 2022
High mobility group protein B1 decreases surface localization of PD-1 to augment T-cell activation
Qun Gao; Shumin Wang; Feng Li; Jingyao Lian; Shaoyan Cheng; Dongli Yue; Zhen Zhang; Shasha Liu; Feifei Ren; Daiqun Zhang; Shengdian Wang; Liping Wang; Yi Zhang
Cancer Immunol Res canimm.0652.2021.
Research Article May 17 2022
Modified manufacturing process modulates CD19CAR T-cell engraftment fitness and leukemia-free survival in pediatric and young adult subjects
Francesco Ceppi; Ashley L. Wilson; Colleen Annesley; Gabriella R. Kimmerly; Corinne Summers; Adam Brand; Kristy Seidel; Qian Vicky Wu; Adam Beebe; Christopher Brown; Stephanie Mgebroff; Catherine Lindgren; Stephanie D. Rawlings-Rhea; Wenjun Huang; Michael A. Pulsipher; Alan S. Wayne; Julie R. Park; Michael C. Jensen; Rebecca A. Gardner
Cancer Immunol Res canimm.CIR-21-0501-E.2021.
Research Article May 13 2022
Epigenetic repression of STING by MYC promotes immune evasion and resistance to immune checkpoint inhibitors in triple negative breast cancer
Kyung-min Lee; Chang-Ching Lin; Alberto Servetto; Joonbeom Bae; Vishal Kandagatla; Dan Ye; Gun Min Kim; Dhivya R. Sudhan; Saurabh Mendiratta; Paula I. Gonzalez-Ericsson; Justin M. Balko; Jeon Lee; Spencer Barnes; Venkat S. Malladi; Siamak Tabrizi; Sangeetha M. Reddy; Seoyun Yum; Ching-Wei Chang; Katherine E. Hutchinson; Susan E. Yost; Yuan Yuan; Zhijian J. Chen; Yang-Xin Fu; Ariella B. Hanker; Carlos L. Arteaga
Cancer Immunol Res canimm.0826.2021.
Research Article May 11 2022
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
Carlos R. Gil Del Alcazar; Anne Trinh; Maša Alečković; Ernesto Rojas Jimenez; Nicholas W. Harper; Michael U.J. Oliphant; Shanshan Xie; Ethan D. Krop; Bethlehem Lulseged; Katherine C. Murphy; Tanya E. Keenan; Eliezer M. Van Allen; Sara M. Tolaney; Gordon J. Freeman; Deborah A. Dillon; Senthil K. Muthuswamy; Kornelia Polyak
Cancer Immunol Res (2022)
Research Article May 11 2022
Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma
Saketh S. Dinavahi; Yu-Chi Chen; Kishore Punnath; Arthur Berg; Meenhard Herlyn; Momeneh Foroutan; Nicholas D. Huntington; Gavin P. Robertson
Cancer Immunol Res (2022)
Article Commentary May 11 2022
Revival and Recharacterization of a Preclinical Model of Hormone-Dependent Breast Cancer to Study Immunotherapy
Cancer Immunol Res (2022)
Research Article May 10 2022
T Cell–Mediated Targeted Delivery of Anti–PD-L1 Nanobody Overcomes Poor Antibody Penetration and Improves PD-L1 Blocking at the Tumor Site
Pierre-Florent Petit; Raphaële Bombart; Pierre-Hubert Desimpel; Stefan Naulaerts; Laurie Thouvenel; Jean-François Collet; Benoit J. Van den Eynde; Jingjing Zhu
Cancer Immunol Res (2022)
Research Article May 10 2022
Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients
Adel Samson; Emma J. West; Jonathan Carmichael; Karen J. Scott; Samantha Turnbull; Bethany Kuszlewicz; Rajiv V. Dave; Adam Peckham-Cooper; Emma Tidswell; Jennifer Kingston; Michelle Johnpulle; Barbara da Silva; Victoria A. Jennings; Kaidre Bendjama; Nicolas Stojkowitz; Monika Lusky; K. R. Prasad; Giles J. Toogood; Rebecca Auer; John Bell; Chris J. Twelves; Kevin J. Harrington; Richard G. Vile; Hardev Pandha; Fiona Errington-Mais; Christy Ralph; Darren J. Newton; Alan Anthoney; Alan A. Melcher; Fiona Collinson
Cancer Immunol Res (2022)
Research Article May 4 2022
Visualizing Spatial and Stoichiometric Barriers to Bispecific T-Cell Engager Efficacy
Ran You; Jordan Artichoker; Arja Ray; Hugo Gonzalez Velozo; Dan A. Rock; Kip P. Conner; Matthew F. Krummel
Cancer Immunol Res (2022)
Research Article May 3 2022
Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma
Wenjing Xuan; Wen-Hao Hsu; Fatima Khan; Madeline Dunterman; Lizhi Pang; Derek A. Wainwright; Atique U. Ahmed; Amy B. Heimberger; Maciej S. Lesniak; Peiwen Chen
Cancer Immunol Res (2022)
Review Article April 26 2022
Coming of Age: Human Genomics and the Cancer–Immune Set Point
Cancer Immunol Res (2022)
Advertisement
